Lantheus Holdings
Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica, MA 01862
Phone: (800) 299-3431Website: https://www.lantheus.com/Careers: www.lantheus.com/about/careers
Latest news
- FDA Approves Azedra (iobenguane I 131) for Rare Adrenal Tumors
30 July 2018 - Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for Azedra (iobenguane I 131)
22 March 2018 - Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for Azedra (iobenguane I 131) in Pheochromocytoma and Paraganglioma
29 December 2017 - Progenics Pharmaceuticals Completes Submission of NDA for Azedra (iobenguane I 131) in Pheochromocytoma and Paraganglioma
2 November 2017
Drugs Associated with Lantheus Holdings, Inc.
Lantheus Holdings, Inc. manufactures, markets and/or distributes more than 7 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Azedra
Generic name: iobenguane I 131 Drug class: therapeutic radiopharmaceuticals |
||
Cardiolite
Generic name: sestamibi Drug class: radiologic conjugating agents |
1 review | 10 / 10 |
Definity
Generic name: perflutren Drug class: ultrasound contrast media |
5 reviews | 3.4 / 10 |
Neurolite
Generic name: bicisate dihydrochloride Drug class: radiologic conjugating agents |
||
Pylarify
Generic name: piflufolastat F 18 Drug class: diagnostic radiopharmaceuticals |
||
Technelite
Generic name: sodium pertechnetate (tc-99m) Drug class: diagnostic radiopharmaceuticals |
||
xenon xe-133
Generic Drug class: diagnostic radiopharmaceuticals |
||
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |